Literature DB >> 1958396

Biological response in vitro to pulsed high dose rate electrons from a clinical accelerator.

B U Zackrisson1, U H Nyström, P Ostbergh.   

Abstract

Several studies of biological response to ionizing radiation of high absorbed dose rates have been performed, often with conflicting results. The aim of this study was to establish whether a difference between irradiation at high dose rates and at more conventional dose rates could be verified. Pulsed 50 MeV electrons from a clinical accelerator were used both for the high dose rate experiments (mean dose rate: 3.8 x 10(2) Gy/s) and the reference experiments (mean dose rate: 9.6 x 10(-2) Gy/s). In this study V-79 cells were irradiated in vitro. The experiments were carried out under both oxic and anoxic conditions. No significant difference in relative biological effectiveness (RBE) or oxygen enhancement ratio (OER) was observed at the different dose rates investigated.

Entities:  

Mesh:

Year:  1991        PMID: 1958396     DOI: 10.3109/02841869109092451

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  3 in total

Review 1.  FLASH and minibeams in radiation therapy: the effect of microstructures on time and space and their potential application to protontherapy.

Authors:  Alejandro Mazal; Yolanda Prezado; Carme Ares; Ludovic de Marzi; Annalisa Patriarca; Raymond Miralbell; Vincent Favaudon
Journal:  Br J Radiol       Date:  2020-02-12       Impact factor: 3.039

2.  Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions.

Authors:  Gabriel Adrian; Elise Konradsson; Sarah Beyer; Anders Wittrup; Karl T Butterworth; Stephen J McMahon; Mihaela Ghita; Kristoffer Petersson; Crister Ceberg
Journal:  Front Oncol       Date:  2021-07-29       Impact factor: 6.244

3.  The FLASH effect depends on oxygen concentration.

Authors:  Gabriel Adrian; Elise Konradsson; Michael Lempart; Sven Bäck; Crister Ceberg; Kristoffer Petersson
Journal:  Br J Radiol       Date:  2019-12-20       Impact factor: 3.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.